Literature DB >> 19586422

Endophthalmitis after intravitreal injections.

Stephen G Schwartz1, Harry W Flynn, Ingrid U Scott.   

Abstract

Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19586422     DOI： 10.1517/14656560903081752

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


  12 in total

1.  Combination of lidocaine gel and povidone-iodine to decrease acquired infections in procedures performed using topical anesthesia.

Authors:  Julia Xia; Riley J Lyons; Mung Yan Lin; Yousuf M Khalifa; Christopher N LaRock
Journal:  J Cataract Refract Surg       Date:  2020-07       Impact factor: 3.351

Review 2.  Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.

Authors:  Rachel R Hartman; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-05       Impact factor: 2.671

3.  Endophthalmitis following intravitreal injections.

Authors:  Cristina Irigoyen; Kimia Ziahosseini; George Morphis; Theodor Stappler; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-03       Impact factor: 3.117

4.  Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.

Authors:  Ludimila L Cavalcante; Milena L Cavalcante; Timothy G Murray; Michael M Vigoda; Yolanda Piña; Christina L Decatur; R Prince Davis; Lisa C Olmos; Amy C Schefler; Michael B Parrott; Kyle J Alliman; Harry W Flynn; Andrew A Moshfeghi
Journal:  Clin Ophthalmol       Date:  2010-05-25

5.  Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2014-03-01

6.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

Review 7.  Ocular Infection: Endophthalmitis.

Authors:  Stephen G Schwartz; Harry W Flynn; Taraprasad Das; William F Mieler
Journal:  Dev Ophthalmol       Date:  2015-10-26

8.  Intravitreal Corticosteroids in the Management of Diabetic Macular Edema.

Authors:  Stephen G Schwartz; Harry W Flynn; Ingrid U Scott
Journal:  Curr Ophthalmol Rep       Date:  2013-09

9.  Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center".

Authors:  Inci Elif Erbahçeci; Kemal Ornek
Journal:  Retina       Date:  2012-06       Impact factor: 3.975

Review 10.  Emerging pharmacotherapies for diabetic macular edema.

Authors:  Golnaz Javey; Stephen G Schwartz; Harry W Flynn
Journal:  Exp Diabetes Res       Date:  2012-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.